ÂÜÀòÂÒÂ×

With more than 15 years of experience in finance and accounting disciplines at publicly traded early-stage biotechnology companies, Ms. Clennett joined Aptose in 2017 as Director of Finance and was promoted to Vice President, Finance in 2021. She continues to oversee financial operations, including financial reporting and accounting. Her experience includes participation in and support of multiple financing transactions and clinical programs. Prior, Ms. Clennett was Director of Finance and Acting CFO at ProMIS Neurosciences, and Controller and Chief Financial Officer at Fralex Therapeutics. She is a Chartered Professional Accountant (CPA) and a graduate of the University of Waterloo, Canada.